Jacek Zachwieja
Overview
Explore the profile of Jacek Zachwieja including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
72
Citations
399
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zagozdzon I, Szczepanska M, Leszczynska B, Jarmuzek W, Miklaszewska M, Tkaczyk M, et al.
J Clin Med
. 2024 Nov;
13(21).
PMID: 39518638
: Hemolytic uremic syndrome (HUS) is a known cause of acute kidney injury in children, but there are few recent reports on its epidemiology and outcome. We aimed to investigate...
2.
Sobiak J, Resztak M, Sikora W, Zachwieja J, Ostalska-Nowicka D
Pharmacol Rep
. 2024 Jun;
76(4):910.
PMID: 38916851
No abstract available.
3.
Soltysiak J, Skowronska B, Mackowiak-Lewandowicz K, Blumczynski A, Elzbieta K, Ostalska-Nowicka D, et al.
Pediatr Nephrol
. 2024 Jun;
39(10):3037-3047.
PMID: 38864872
Background: This study aimed to evaluate the blood pressure (BP) status, including arterial stiffness parameters, hemodynamic indicators, circadian profile, and its association with albuminuria in adolescents with type 1 diabetes...
4.
Sobiak J, Resztak M, Sikora W, Zachwieja J, Ostalska-Nowicka D
Pharmacol Rep
. 2024 Mar;
76(3):600-611.
PMID: 38485859
Background: Saliva sampling is one of the methods of therapeutic drug monitoring for mycophenolic acid (MPA) and its metabolite, mycophenolic acid glucuronide (MPAG). The study describes the liquid chromatography tandem...
5.
Sobiak J, Resztak M, Banasiak J, Zachwieja J, Ostalska-Nowicka D
Pharmacol Rep
. 2023 Mar;
75(3):726-736.
PMID: 36905501
Background: For therapeutic drug monitoring (TDM) of mycophenolic acid (MPA), which is frequently proposed, saliva might be a suitable and easy-to-obtain biological matrix. The study aimed to validate an HPLC...
6.
Sobiak J, Zero P, Zachwieja J, Ostalska-Nowicka D, Pawinski T
Clin Exp Pharmacol Physiol
. 2023 Feb;
50(6):486-496.
PMID: 36846865
In paediatric patients, there is no data on the recommended area under the concentration-time curve from 0 to 12 h (AUC ) for free mycophenolic acid (fMPA), which is the...
7.
Soltysiak J, Krzysko-Pieczka I, Gertig-Kolasa A, Mularz E, Skowronska B, Ostalska-Nowicka D, et al.
Pediatr Nephrol
. 2022 Oct;
38(5):1643-1652.
PMID: 36227434
Background: Diabetic ketoacidosis (DKA) and hyperglycaemia without ketoacidosis are common acute complications of diabetes. Their association with acute kidney injury (AKI) and diabetic kidney disease (DKD) was studied. Methods: The...
8.
Sobiak J, Resztak M, Zachwieja J, Ostalska-Nowicka D
Clin Exp Pharmacol Physiol
. 2022 Jul;
49(11):1197-1208.
PMID: 35877984
Some studies have shown that the area under the concentration-time curve (AUC) of mycophenolic acid (MPA) should be higher for children with nephrotic syndrome (NS) than after renal transplantation. The...
9.
Mackowiak-Lewandowicz K, Ostalska-Nowicka D, Zaorska K, Kaczmarek E, Zachwieja J, Witt M, et al.
Pediatr Nephrol
. 2022 Feb;
37(10):2479-2488.
PMID: 35211791
Background: Glomerular hyperfiltration, initiating development of obesity-related glomerulopathy, results in an enlargement of the glomeruli and unsealing of the filtration barrier. It can be followed by adaptive focal segmental glomerulosclerosis...
10.
Mizerska-Wasiak M, Gajewski L, Cichon-Kawa K, Siejko A, Maldyk J, Splawa-Neyman A, et al.
Cent Eur J Immunol
. 2021 Nov;
46(2):199-209.
PMID: 34764788
Aim Of The Study: To evaluate the relationship between serum Gd-IgA1 (sGd-IgA1) and serum and urine TNFR1 (sTNFR1, uTNFR1) levels as possible prognostic factors in IgA nephropathy (IgAN) and IgA...